Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Feb 28;16(1):1-6.
doi: 10.9758/cpn.2018.16.1.1.

The Present and Future of Precision Medicine in Psychiatry: Focus on Clinical Psychopharmacology of Antidepressants

Affiliations
Review

The Present and Future of Precision Medicine in Psychiatry: Focus on Clinical Psychopharmacology of Antidepressants

Alessandro Serretti. Clin Psychopharmacol Neurosci. .

Abstract

Precision medicine is a concept which is recently gaining momentum in all branches of medicine. In particular in psychiatry it is greatly needed given the huge societal costs of psychiatric disorders and given the long time needed to observe benefit from treatments and the response variability. The future will be based on biological determinants, however until such an interesting but still futuristic aim will be reached, at present we may only rely on clinical features to guide our individualized prescription which is currently still frequently based on personal opinion and subjective previous experiences. The aim of this review is to offer an overview of the main aspects to take into consideration when prescribing an antidepressant treatment to reach the best precision medicine using clinical information. More than 40 compounds are available for treating depression and a similar amount of compounds for other psychiatric disorders. The process of matching the profile of the patient with all different profiles of available compounds is therefore quite complex. Our everyday prescribing procedure should take into consideration a number of factors such as the knowledge of the profile of available compounds versus the symptomatology profile of the subject, previous efficacy, medical comorbidities, tolerability profile, individual preferences, and family history. While we are waiting more complex algorithms including biological or genetic measures, it is possible to optimize our current prescription practice by using all available information in order to obtain as much as possible an evidence based precision medicine prescription.

Keywords: Antidepressive agents; Depression; Precision medicine; Psychiatry; Psychopharmacology.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Tolerability profile of most common antidepressants based on published meta analyses. Darkness indicates more side effects, while brightness for less side effects.

References

    1. Serretti A, Mandelli L. Antidepressants and body weight: a comprehensive review and meta-analysis. J Clin Psychiatry. 2010;71:1259–1272. doi: 10.4088/JCP.09r05346blu. - DOI - PubMed
    1. Alberti S, Chiesa A, Andrisano C, Serretti A. Insomnia and somnolence associated with second-generation antidepressants during the treatment of major depression: a metaanalysis. J Clin Psychopharmacol. 2015;35:296–303. doi: 10.1097/JCP.0000000000000329. - DOI - PubMed
    1. Delavenne X, Magnin M, Basset T, Piot M, Mallouk N, Ressnikoff D, et al. Investigation of drug-drug interactions between clopidogrel and fluoxetine. Fundam Clin Pharmacol. 2013;27:683–689. doi: 10.1111/fcp.12021. - DOI - PubMed
    1. Fabbri C, Crisafulli C, Calabrò M, Spina E, Serretti A. Progress and prospects in pharmacogenetics of antidepressant drugs. Expert Opin Drug Metab Toxicol. 2016;12:1157–1168. doi: 10.1080/17425255.2016.1202237. - DOI - PubMed
    1. Perlis RH. Abandoning personalization to get to precision in the pharmacotherapy of depression. World Psychiatry. 2016;15:228–235. doi: 10.1002/wps.20345. - DOI - PMC - PubMed